Magnitude and associated factors of Atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia

BMC Family Practice

Sefonias Getachew³  Ashenafi Shumye²  Workalemahu Alemu¹  Abraham Getachew Kelbore⁴ 

[1] Dermatovenereology Department, Mekelle University, Mekelle, North Ethiopia;Public Health Department, Mekelle University, Mekelle, North Ethiopia;Addis Ababa University, School of Public Health, Addis Ababa, Ethiopia;Mekelle University, Tropical Dermatology, Mekelle, North Ethiopia

关键词: Institutional based study;    Magnitude;    Cross sectional study;    Atopic dermatitis;   

Others  :  1224024
DOI  :  10.1186/s12895-015-0034-x

 received in 2015-01-17, accepted in 2015-08-05,  发布年份 2015

【 摘 要 】

Background

Atopic Dermatitis (AD) is now a day’s increasing in prevalence globally. A Prevalence of 5–25 % have been reported in different country. Even if its prevalence is known in most countries especially in developing countries there is scarcity with regard to prevalence and associated risk factors of AD among children in Ethiopia settings. The aim of this study was to determine the magnitude and associated factors of atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia.

Methods

A facility-based cross-sectional study design was conducted among 477 children aged from 3 months to 14 years in Ayder referral hospital from July to September, 2014. A systematic random sampling technique was used to identify study subjects. Descriptive analysis was done to characterize the study population. Bivariate and multivariate logistic regression was used to identify factors associated with AD. The OR with 95 % CI was used to show the strength of the association and a P value < 0.05 was used to declare the cut of point in determining the level of significance.

Results

Among the total respondents, 237 (50.4 %) were males and 233 (49.6 %) were females. The magnitude of the atopic dermatitis was found to be 9.6 % (95 % CI: 7.2, 12.5). In multivariate logistic regression model, those who had maternal asthma (AOR: 11.5, 95 % CI:3.3–40.5), maternal hay fever history (AOR: 23.5, 95 % CI: 4.6–118.9) and atopic dermatitis history (AOR: 6.0, 95 % CI:1.0–35.6), Paternal asthma (AOR: 14.4, 95 % CI:4.0–51.7), Paternal hay fever history (AOR: 13.8, 95 % CI: 2.4–78.9) and personal asthma (AOR: 10.5, 95 % CI:1.3–85.6), and hay fever history (AOR: 12.9, 95 % CI:2.7–63.4), age at 3 months to 1 year (OR: 6.8, 95 % CI: 1.1–46.0) and weaning at 4 to 6 months age (AOR: 3.9, 95 % CI:1.2–13.3) were a significant predictors of atopic dermatitis.

Conclusion

In this study the magnitude of atopic dermatitis was high in relation to other studies conducted so far in the country. Maternal, paternal, personal asthma, hay fever histories, maternal atopic dermatitis history, age of child and age of weaning were independent predicators of atopic dermatitis. Hence, the finding alert a needs of strengthening the national skin diseases prevention and control services in particular in skin care of children related to atopic dermatitis and others. In avoiding early initiation of supplementary feeding specially with personal and families with atopic problem needs further attention of prevention activities.

【 授权许可】

   
2015 Kelbore et al.

【 图 表 】

Fig. 1.

Fig. 2.

Fig. 3.

【 参考文献 】

• [1]Donal Y, Lawerence F, Boguniewic Z et al.. Atopic dermatitis. In: Fitzpatrick’s dermatology in general medicine. Wolff K, Wella A, Katz S, editors. McGraw-Hill, New York; 2008: p.146-150.
• [2]Friedmann P, Ardern M, Cox N et al.. Atopic dermatitis. In: Rook’s text book of dermatology. Burns T, Breathnack S, editors. Black publishing ltd, UK; 2010: p.1037-1046.
• [3]Van den Oord RA, Sheikh A. Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysis. BMJ. 2009; 339:24-33.
• [4]Palmer CN, Irvine AD, Terron-Kwiatkowski A et al.. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006; 38(4):441-446.
• [5]Rautan S, Walker A et al.. Immunophyisiology and nutrition of the gut. In: Nutrition in pediatrics. Duggan C, editor. BC Decker, Canada; 2008: p.252-256.
• [6]Böttcher MF, Jenmalm MC. Breastfeeding and the development of atopic disease during childhood. Clin Exp Allergy. 2002; 32:159-161.
• [7]Williams HC, Burney PG, Hay RJ et al.. The U.K. Working Party’s Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol. 1994; 131(3):383-396.
• [8]Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Dermato-Venereologica. 1980;(Suppl 92):44–7.
• [9]Williams HC. Atopic dermatitis. N Engl J Med. 2005; 352:2314-2324.
• [10]Atopic dermatitis in children. Management of atopic dermatitis in children from birth up to the age of 12 years. NICE clinical guideline 57. NICE, London; 2007.
• [11]Asher MI, Montefort S, Bjorksten B et al.. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006; 368:733-743.
• [12]Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet. 1998; 351:1225-1232.
• [13]Haileamlak A, Dagoye D, Williams H et al.. Early life risk factors for atopic Dermatitis in Ethiopian children. J Allergic Clin Immunol. 2005; 115:370-376.
• [14]Diepgen T. Is the prevalence of atopic dermatitis increasing? In: Atopic dermatitis. Williams HC, editor. Cambridge University Press, Cambridge; 2000: p.96-112.
• [15]Park CK, Park CW, Lee CH. Quality of life and the family impact ofatopic dermatitis in children. Korean J Dermatol. 2007; 45:429-438.
• [16]Charman CR, Morris AD, Williams HC. Topical corticosteroid phobia in patients with atopic eczema. Br J Dermatol. 2000; 142(5):931-936.
• [17]Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young childrenwith atopic dermatitis--a prospective follow-up to 7 years of age. Allergy. 2000; 55(3):240-245.
• [18]Jackson KM, Nazar AM. Breastfeeding, the Immune Response, and Long-term Health. J Am Osteopath Assoc. 2006; 106:203-207.
• [19]Ludvigsson JF, Mostrom M, Ludvigsson J et al.. Exclusive breast feeding and risk of atopic dermatitis in infants. Pediatr Allergy Immunol. 2005; 16:201-208.
• [20]Dagoye D, Bekele Z, Woldemichael K, Nida H, Yimam M, Venn AJ et al.. Domestic risk factors for wheeze in urban and rural Ethiopianchildren. Q J Med. 2004; 97:1-11.
• [21]Ethiopia Demographic and Health Survey 2011. Central statistical agency and ICF International, Addis Ababa, Ethiopia, Calverton, Maryland, USA; 2012.
• [22]Tigray Regional State. Bureau of Plan and Finance Five Years (2010/11–2014/15) Growth & Transformation Plan, Mekelle, E.C; 2003
• [23]Nigusse S, Beraldo M, Shibeshi D et al.. A Mobile Community Dermatologic Clinic in Ankober Woreda, Central Ethiopia. Comm Dermatol J. 2013; 8:1-12.
• [24]Simpson EL, Hanifin JM. Atopic dermatitis. Med Clin North Am. 2006; 90(1):149-167.
• [25]ISAAC, 1998. International Study of Asthma and Allergies in Childhood (ISAAC), Phase Three Manual. Available at: http://isaac.auckland.ac.nz/Phasethr/Phs3Frame.html. Accessed on 20 May 2014.
• [26]Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Invest Dermatol. 2011; 131:67.
• [27]New-Dei-Cas I, Dei-Cas P, Acuña K. Atopic dermatitis and risk factors in poor children from Great Buenos Aires, Argentina. Clin Exp Dermatol. 2009; 34(3):299-303.
• [28]Miyake Y, Tanaka K, Sasaki S et al.. Breastfeeding and atopic eczema in Japanese infants: The Osaka Maternal and Child Health Study. Pediatr Allergy Immunol. 2009; 20:234-241.
• [29]Amouri M, Masmoudi A, Borgi N et al.. Atopic dermatitis in Tunisian school children. Pan Afr Med J. 2011; 9:34.
• [30]Wang IJ, Guo YL, Hwang KC, Hsieh WS, Chuang YL, Lin SJ, Chen PC. Genetic and environmental predictors for pediatric atopic dermatitis. Acta Pediatric Taiwan. 2006; 47(5):238-242.
• [31]Farajzadeh S, Shahesmaeili A, Bagargan N et al.. Relationship between duration of breastfeeding and development of atopic dermatitis. J Pakisan Association Dermatologists. 2011; 21:80-86.
• [32]Yang YM, Tsai CL, Lu CY. Exclusive breastfeeding and incident atopic dermatitis in childhood: a systematic review and meta-analysis of prospective cohort studies. Br J Dermatol. 2009; 161(2):373-383.
• [33]Sahakyan A. Risk Factors Associated with the Development of Atopic Dermatitis among Children in Yerevan:A case- control study college of health science, Yerevan, 2003.
• [34]Obihara CC, Marals BJ, Gie RP, et al. The Association of Prolonged Breastfeeding and Allergic Disease in Poor Urban. Children Eur Respir J. 2005;25:970–7.
• [35]Lee S, Kim J, Han Y. Atopic dermatitis organizer guild line for children. Asia Pack Allergy. 2011; 1:53-63.
• [36]Kull I, Maria B, Wahlgren C et al.. Breast-feeding reduces the risk for childhood eczema. J Allergy Clin Immunol. 2005; 116:657-661.
• [37]Schram ME, Tedja Am Spijker R et al.. Is there a rural/urban gradient in the prevalence of dermatitis? A systematic review. Br J Dermatol. 2010; 162:964-973.
• [38]Flohr C, Pascoe D, Williams HC. Atopic dermatitis and the “hygiene hypothesis”: too clean to be true? Br J Dermatol. 2005; 152:202-216.
• [39]Shams K, Grindlay DJC, Williams HC. What”s new in atopic dermatitis? An analysis of systematic reviews published in 2009–2010. Clin Exp Dermatol. 2011; 36:573-578.
• [40]Obeng BB, Hartgers F, Boakye D, Yazdanbakhsh M. Out of Africa: what can be learned from the studies of allergic disorders in Africa and Africans? Curr Opinion Allergy Clin Immunol. 2008; 8:391-397.
• [41]Purvis DJ, Thompson JMD, Clark PM et al.. Risk Factors for Atopic Dermatitis in New Zealand Children at 3.5 Years of Age. Br J Dermatol. 2005; 152:742-749.